When will China Pharmaceuticals release a PDA

The American Injectables Association (PDA), it is possible that many young practitioners in the industry may confuse the FDA.

Reading the day before yesterday, a guide mentioned that the joint meeting between the FDA and PDA was one of the important reasons for the birth of the guide

The author can't help thinking that a few years ago, NMPA, also called SFDA, took the lead in demonstrating and spun off the training institutions originally affiliated with it, but at the same time raised expectations that the private sector could emerge authoritatively and help regulatory agencies improve

Many years have passed, and the private training institutions in the industry are in full swing.

And the technological level of the industry is advancing, ha ha

The historical problems left over by the Chinese pharmaceutical industry are still poisoned today

Not to mention, some outdated and old-fashioned so-called national standards have been issued by some sloppy industry associations and a few so-called experts in the upstream and downstream industries, which also makes the real industry people disdain to criticize

Promoting the progress of the industry, the official is very tired.

So, the question is, where is the PDA in China? Bringing together the voices of the industry, on the one hand, guide the progress of the industry, on the other hand, promote the regulators to improve the supervision model

The search shows that the American Injectables Association (PDA) is the world's leading facilitator of scientific, technical and regulatory information

To talk about the communication platform of the domestic pharmaceutical industry, it is the Dandelion Forum, which is also a non-profit organization

On the other hand, I am accustomed to the unilateral publicity and training by several experts, but ignore the creation of industry technical reports that have left a shadow after a century of planting trees

All of the above do not match the expectations of the domestic pharmaceutical industry for overtaking in corners, especially biopharmaceuticals